TOI Historical PE Ratio Notes

— The Oncology Institute, Inc. (ticker symbol TOI) is a leading value-based oncology healthcare provider focused on delivering comprehensive cancer care across the United States. The company operates outpatient cancer clinics, providing services that include medical oncology, hematology, infusion therapy, diagnostics, and supportive care. TOI distinguishes itself by emphasizing patient-centered treatment models and leveraging data-driven protocols to enhance outcomes & reduce costs—an approach that positions the company as a disruptor in the traditional fee-for-service oncology space. As you examine TOI’s historical PE ratio, keep in mind that investor sentiment and expectations regarding TOI’s growth trajectory, profitability, and risk profile are all factors reflected in these valuations. Because TOI has prioritized expansion and investments in its infrastructure, there may be periods with suppressed or even negative earnings, contributing to high or undefined PE ratios in certain historical stretches. Volatility in the PE ratio may also reflect the market’s evolving perspective on TOI’s ability to scale profitably within a heavily regulated, competitive segment of the healthcare industry. Understanding these business fundamentals will help you contextualize the underlying trends in the historical price, earnings, and PE ratio data you are about to review.

On this page we presented the The Oncology Institute Historical PE Ratio information for The Oncology Institute' stock. The average TOI historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 6.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average TOI historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this TOI historical PE result, against the recent PE: when this page was posted on 8/3/2026, the most recent closing price for TOI had been 5.13, and the most recent quarterly earnings result, annualized, was 0.84. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent TOI PE on 8/3/2026 based on annualized quarterly EPS was 6.1. Based on TOI's history, that recent PE is low relative to the historical average, with the recent PE 9.0% lower than the historical average PE across our data set for The Oncology Institute.

For self directed investors doing their due diligence on TOI or any other given stock, valuation analysis for TOI can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate The Oncology Institute PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for TOI. Thanks for visiting, and the next time you need to research TOI Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.